David A. Siegel Globus Medical Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Globus Medical Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 91,900 shares of GMED stock, worth $7.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

91,900

Previous 529,875 82.66%

Holding current value

$7.6 Million

Previous $36.3 Million 81.89%

% of portfolio

0.02%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.08 - $73.92 $29.4 Million - $32.4 Million	-437,975 Reduced 82.66%	91,900 $6.57 Million
Q2 2024 Aug 14, 2024	SELL	$49.79 - $68.85 $10 Million - $13.8 Million	-201,100 Reduced 27.51%	529,875 $36.3 Million
Q1 2024 May 15, 2024	SELL	$51.15 - $56.52 $3.14 Million - $3.47 Million	-61,400 Reduced 7.75%	730,975 $39.2 Million
Q4 2023 Feb 14, 2024	SELL	$43.79 - $55.14 $24.2 Million - $30.4 Million	-552,125 Reduced 41.07%	792,375 $42.2 Million
Q3 2023 Nov 14, 2023	BUY	$49.1 - $62.37 $23 Million - $29.2 Million	468,000 Added 53.39%	1,344,500 $66.8 Million
Q2 2023 Aug 14, 2023	BUY	$52.61 - $59.54 $39 Million - $44.2 Million	741,900 Added 551.19%	876,500 $52.2 Million
Q1 2023 May 15, 2023	BUY	$51.83 - $79.63 $6.51 Million - $10 Million	125,600 Added 1395.56%	134,600 $7.62 Million
Q4 2022 Feb 14, 2023	SELL	$58.4 - $75.53 $292,000 - $377,650	-5,000 Reduced 35.71%	9,000 $668,000
Q3 2022 Nov 14, 2022	SELL	$55.32 - $67.54 $304,260 - $371,470	-5,500 Reduced 28.21%	14,000 $834,000
Q2 2022 Aug 15, 2022	SELL	$53.08 - $81.37 $684,732 - $1.05 Million	-12,900 Reduced 39.81%	19,500 $1.1 Million
Q1 2022 May 16, 2022	BUY	$63.68 - $75.54 $713,216 - $846,048	11,200 Added 52.83%	32,400 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$62.62 - $79.92 $2.05 Million - $2.61 Million	-32,700 Reduced 60.67%	21,200 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$76.41 - $84.06 $13.8 Million - $15.2 Million	-180,600 Reduced 77.01%	53,900 $4.13 Million
Q2 2021 Aug 16, 2021	BUY	$61.85 - $77.53 $6.79 Million - $8.51 Million	109,800 Added 88.05%	234,500 $18.2 Million
Q1 2021 May 17, 2021	BUY	$60.05 - $67.74 $3.25 Million - $3.66 Million	54,100 Added 76.63%	124,700 $7.69 Million
Q4 2020 Feb 16, 2021	SELL	$48.89 - $65.87 $2.66 Million - $3.58 Million	-54,400 Reduced 43.52%	70,600 $4.61 Million
Q3 2020 Nov 16, 2020	BUY	$45.26 - $57.82 $5.66 Million - $7.23 Million	125,000 New	125,000 $6.19 Million
Q2 2020 Aug 14, 2020	SELL	$39.81 - $55.61 $632,979 - $884,199	-15,900 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$35.06 - $59.45 $5.75 Million - $9.76 Million	-164,100 Reduced 91.17%	15,900 $676,000
Q4 2019 Feb 14, 2020	BUY	$49.45 - $59.5 $8.49 Million - $10.2 Million	171,700 Added 2068.67%	180,000 $10.6 Million
Q3 2019 Nov 14, 2019	BUY	$40.41 - $52.32 $44,450 - $57,552	1,100 Added 15.28%	8,300 $424,000
Q2 2019 Aug 14, 2019	SELL	$39.3 - $48.41 $2.9 Million - $3.57 Million	-73,804 Reduced 91.11%	7,200 $305,000
Q1 2019 May 15, 2019	SELL	$38.08 - $49.41 $1.73 Million - $2.25 Million	-45,500 Reduced 35.97%	81,004 $4 Million
Q4 2018 Feb 14, 2019	SELL	$41.38 - $57.44 $1.74 Million - $2.42 Million	-42,106 Reduced 24.97%	126,504 $5.48 Million
Q3 2018 Nov 14, 2018	BUY	$50.24 - $56.76 $170,816 - $192,984	3,400 Added 2.06%	168,610 $9.57 Million
Q2 2018 Aug 14, 2018	BUY	$47.96 - $57.41 $2.48 Million - $2.97 Million	51,800 Added 45.67%	165,210 $8.34 Million
Q1 2018 May 15, 2018	BUY	$42.75 - $51.73 $1.04 Million - $1.26 Million	24,300 Added 27.27%	113,410 $5.65 Million
Q4 2017 Feb 14, 2018	SELL	$28.86 - $41.64 $40,404 - $58,296	-1,400 Reduced 1.55%	89,110 $3.66 Million
Q3 2017 Nov 14, 2017	BUY	$28.28 - $30.85 $2.56 Million - $2.79 Million	90,510	90,510 $2.69 Million

Others Institutions Holding GMED

# of Institutions

479

Shares Held

104M

Call Options Held

183K

Put Options Held

57.3K

View Full List

About GLOBUS MEDICAL INC

Ticker GMED
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 77,037,200
Market Cap $6.37B
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...

More about GMED

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account